Charles Schwab’s Actinium Pharmaceuticals ATNM Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | – | Sell |
-97,604
| Closed | -$157K | – | 3500 |
|
|
2025
Q1 | $157K | Buy |
97,604
+25,511
| +35% | +$41.1K | ﹤0.01% | 3288 |
|
|
2024
Q4 | $90.8K | Hold |
72,093
| – | – | ﹤0.01% | 3405 |
|
|
2024
Q3 | $136K | Sell |
72,093
-11,484
| -14% | -$21.6K | ﹤0.01% | 3364 |
|
|
2024
Q2 | $618K | Buy |
83,577
+7,369
| +10% | +$54.5K | ﹤0.01% | 3101 |
|
|
2024
Q1 | $597K | Hold |
76,208
| – | – | ﹤0.01% | 2961 |
|
|
2023
Q4 | $387K | Hold |
76,208
| – | – | ﹤0.01% | 3162 |
|
|
2023
Q3 | $451K | Buy |
76,208
+4,216
| +6% | +$25K | ﹤0.01% | 3080 |
|
|
2023
Q2 | $534K | Buy |
71,992
+59,466
| +475% | +$441K | ﹤0.01% | 3018 |
|
|
2023
Q1 | $118K | Buy |
+12,526
| New | +$118K | ﹤0.01% | 3226 |
|
|
2020
Q3 | – | Sell |
-2,674
| Closed | -$29K | – | 3347 |
|
|
2020
Q2 | $29K | Hold |
2,674
| – | – | ﹤0.01% | 3277 |
|
|
2020
Q1 | $16K | Hold |
2,674
| – | – | ﹤0.01% | 3203 |
|
|
2019
Q4 | $18K | Hold |
2,674
| – | – | ﹤0.01% | 3160 |
|
|
2019
Q3 | $19K | Hold |
2,674
| – | – | ﹤0.01% | 3160 |
|
|
2019
Q2 | $20K | Hold |
2,674
| – | – | ﹤0.01% | 3199 |
|
|
2019
Q1 | $39K | Buy |
+2,674
| New | +$39K | ﹤0.01% | 3170 |
|
|
2015
Q2 | – | Sell |
-970
| Closed | -$72K | – | 3094 |
|
|
2015
Q1 | $72K | Hold |
970
| – | – | ﹤0.01% | 3050 |
|
|
2014
Q4 | $172K | Hold |
970
| – | – | ﹤0.01% | 3004 |
|
|
2014
Q3 | $195K | Hold |
970
| – | – | ﹤0.01% | 2954 |
|
|
2014
Q2 | $211K | Buy |
+970
| New | +$211K | ﹤0.01% | 2982 |
|